Literature DB >> 29767470

Early increase of neutrophil-to-lymphocyte ratio predicts 30-day mortality in patients with spontaneous intracerebral hemorrhage.

Fei Wang1, Feng Xu2, Ye Quan3, Li Wang2, Jian-Jun Xia2, Ting-Ting Jiang1, Li-Juan Shen4, Wen-Hui Kang2, Yong Ding5, Li-Xia Mei5, Xue-Feng Ju2, Shan-You Hu1, Xiao Wu2.   

Abstract

AIMS: To examine whether early rise of neutrophil-to-lymphocyte ratio (NLR) after patient hospitalization correlates with 30-day mortality in patients with spontaneous intracerebral hemorrhage (ICH).
METHODS: This retrospective study included all patients receiving treatment for spontaneous ICH between January 2015 and September 2016 at the Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences in Shanghai, China. NLR was determined at admission (T1), at 24-48 hours (T2) and 5-7 days (T3). NLR and clinicopathologic features were compared between those who survived for >30 days vs not. Multivariate regression was used to identify risk factors for 30-day mortality.
RESULTS: A total of 275 subjects were included in the analysis: 235 survived for at least 30 days; the remaining 40 subjects died within 30 days. The patients who died within 30 days had higher ICH score, larger ICH volume, and lower GCS score (all P < 0.05). In comparison with the baseline (NLRT 1 ), NLR at 24-48 hours (NLRT 2 ) and 5-7 days (NLRT 3 ) was significantly higher in patients who died within 30 days (P < 0.05), but not in patients surviving for >30 days. In the multivariate analysis, the 30-day mortality was associated with both NLRT 2 (OR 1.112, 95%CI 1.032-1.199, P = 0.006) and NLRT 3 (OR 1.163, 95%CI 1.067-1.268, P = 0.001). Spearman correlation analysis showed that both NLRT 2 and NLRT 3 correlated inversely with GCS score and positively with ICH score and ICH volume at the baseline.
CONCLUSIONS: Early rise of NLR predicts 30-day mortality in patients with spontaneous ICH.
© 2018 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  inflammation; mortality; neutrophil-to-lymphocyte ratio; spontaneous intracerebral hemorrhage

Mesh:

Year:  2018        PMID: 29767470      PMCID: PMC6436579          DOI: 10.1111/cns.12977

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


INTRODUCTION

Spontaneous intracerebral hemorrhage (ICH) refers to nontraumatic rupture of primary intracranial blood vessels, allowing blood to flow into the brain parenchyma or cerebral ventricles, resulting in the formation of hematoma that causes neuronal and glial injury and subsequent inflammatory response.1 ICH carries high risk of morbidity and mortality.2 Inflammatory response in ICH is intimately associated with hematoma expansion.3 Neutrophil‐to‐lymphocyte ratio (NLR) is an important determinant of inflammatory response4 and has been proposed as a prognostic indicator in many clinical contexts, including short‐term morbidity and mortality after acute ischemic stroke, ST segment‐elevated myocardial infarction, and acute cardiac insufficiency.5, 6, 7 NLR has also been used as a predictor of long‐term morbidity and mortality in malignancy, autoimmune diseases, and metabolic syndrome.8, 9, 10, 11 In patients with ICH, NLR has been closely associated with 30‐day mortality and 90‐day disability as well as risk of cerebral hematoma enlargement.3, 12, 13, 14 NLR varies with severity of bleeding during hemorrhagic transformation after cerebral thrombolysis15 and with the duration between ICH onset and blood sampling.12, 16, 17 The fact that NLR changes with ICH progression raises the question of under what conditions.13 NLR is a useful prognostic indicator in ICH. In this study, we examined the relationship between NLR at different time points and 30‐day mortality in patients with spontaneous ICH.

METHODS

Study subjects

The initial screen included 307 patients receiving treating for spontaneous ICH at the Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences between January 2015 and September 2016. For inclusion in data analysis, subjects must meet the following criteria: (i) first attack of spontaneous ICH, verified by CT scans; 2) age ≥18 years. Subjects were excluded from analysis if (i) hospital admission was >24 hours after disease onset; (ii) comorbidity with hematologic disorders or a history of malignancy; (iii) use of immunosuppressants of anticoagulants; (iv) a history of infection within the past 2 weeks; (v) stroke within the past 6 months. The final analysis included 275 patients (75.7% men; age range, 27‐94 years). The diagnosis was established by computed tomography (CT) and conforms to the criteria of the American Heart Association and American Stroke Association18 in all 275 cases.

Study methods

Demographic information, medical history (eg, hypertension and diabetes), Glasgow coma scale (GCS) score, and head CT scan results were retrieved from medical records. Hemorrhage location was recorded as supra‐ vs infratentorial based on head CT. Hematoma volume was calculated using the ABC/2 software19 and the formula a  ×  b  ×  c × 1/2, where a refers to hematoma thickness, and b and c refer to the largest vertical diameters of the high‐intensity region on CT scan. ICH score was calculated based on clinical data and CT results.20 Venous blood was obtained at admission (T1; n = 275), at 24‐48 hours after admission (T2; n = 268), and at 5‐7 days after admission (T3; n = 256). For comparison, study subjects were divided artificially into a subgroup surviving for > 30 days (n = 235) vs a subgroup who died within 30 days (n = 40).

Statistical methods

Data were analyzed using SPSS 19.0 (IBM, Chicago, IL, USA). All continuous variables are expressed as median (interquartile range, IQR) and were analyzed using the nonparametric Mann‐Whitney test. Categorical data are expressed as frequencies and were analyzed using the chi‐squared test. Changes of NLR over time were examined using repeated‐measurements test. Spearman correlation was used to analyze factors associated with NLR. Multivariate logistic regression was used to identify risk factors for 30‐day mortality. P < 0.05 was considered statistically significant.

Ethical approval

The study protocol was approved by the Ethics Review Board of Jiading District Central Hospital (2017‐ZD‐03). All subjects were de‐anonymized. Written informed consent was waived by the Ethics Review Board.

RESULTS

A total of 275 subjects were included in the analysis: 235 survived for at least 30 days; the remaining 40 subjects died within 30 days. In comparison with those who survived for at least 30 days, subjects who died within 30 days had significantly lower GCS score, higher score, and hemorrhage volume (P < 0.05 for all; Table 1).
Table 1

Clinicopathologic features in patients who survived or died within 30 d

Survived (n = 235)Died (n = 40) P
Demographics
Male, n (%)178 (75.7)29 (72.5)0.660
Age in yr, median (P25,P75)69 (53, 79)71 (52, 82)0.889
Age ≥80 yr, n (%)57 (24.3)12 (30.0)0.439
Comorbidities, n (%)
Hypertension171 (72.8)27 (67.5)0.493
Diabetes29 (12.3)5 (12.5)0.977
Smoking126 (53.6)25 (62.5)0.297
Alcohol drinking97 (41.3)14 (35.0)0.454
Atrial fibrillation49 (20.9)13 (32.5)0.103
Cerebrovascular disease family history1 (0.4)0 (0.0)1.000
Dyslipidemia62 (26.4)13 (32.5)0.422
Duration from onset to hospitalization, h5.0 (2.0, 15.1)6.3 (2.7, 11.6)0.936
Site of bleeding, n (%)
Supratentorial207 (88.1)33 (82.5)0.327
Infratentorial28 (11.9)7 (17.5)
ICH volume in mL, median (P25,P75)8.9 (3.3, 22.4)45.6 (20.1, 80.0) <0.001
ICH volume ≥30 mL, n (%)42 (17.9)27 (67.5) <0.001
Concurrent ventricular hemorrhage, n (%)58 (24.7)13 (32.5)0.296
GCS score, median (P25,P75)14.0 (12.0, 15.0)8.0 (5.0, 11.0) <0.001
ICH score, median (P25,P75)1.0 (0.0, 2.0)3.0 (2.0, 3.0) <0.001
Blood pressure in mm Hg, median (P25,P75)
Systolic at admission163 (144, 184)170 (141, 190)0.492
Diastolic at admission90 (78, 103)88 (74, 102)0.633
Systolic at 24 h after admission148 (132, 160)147 (131, 158)0.571
Diastolic at 24 h after admission82 (75, 91)87 (73, 92)0.990
Drug use within first week
Mannitol168 (71.5)33 (82.5)0.147
Hyperosmolar saline17 (7.2)3 (7.5)0.952
Corticosteroids22 (9.4)7 (17.5)0.121
Anti‐epileptic drugs7 (3.0)3 (7.5)0.165
Subject number at various times
T12750
T22687
T325619

GCS, Glasgow coma scale; ICH, intracerebral hemorrhage.

The bold values indicate P < 0.05.

Clinicopathologic features in patients who survived or died within 30 d GCS, Glasgow coma scale; ICH, intracerebral hemorrhage. The bold values indicate P < 0.05. The two groups had comparable NLR at admission (Figure 1). In subjects who died within 30 days, early increase in NLR was apparent: NLR was 2.4 (1.4‐6.9) upon admission (T1), 11.3 (8.0‐19.4) at 24‐48 hours (T2), and 12.9 (3.2‐20.1) at 5‐7 days (T3; P = 0.037). In the subjects who survived for at least 30 days, NLR remained relatively stable: 3.3 (1.9‐6.1) at T1, 4.9 (2.8‐7.9) at T2, and 4.2 (2.5‐6.3) at T3 (P = 0.122). At both T2 and T3, NLR was significantly higher in those who died within 30 days (P < 0.05).
Figure 1

NLR over time in the subjects who died within 30 d versus in those surviving for >30 d. T1, at admission; T2, 24‐48 h after admission; T3, 5‐7 d after admission

NLR over time in the subjects who died within 30 d versus in those surviving for >30 d. T1, at admission; T2, 24‐48 h after admission; T3, 5‐7 d after admission In multivariate regression, ICH volume, NLRT2, and NLRT3 were independent risk factors for 30‐day mortality, even after adjustment for other variables (Table 2). NLRT1 was not associated with 30‐day mortality.
Table 2

Potential factors associated with 30‐day mortality: results of multivariate regression

OR95% CI P
Model 1
Male2.5020.9486.6010.064
Age1.0050.9781.0330.718
NLRT1 1.0390.9731.1100.253
ICH volume1.0291.0131.045 <0.001
GCS score0.8380.7400.948 0.005
Infratentorial hemorrhage3.2131.02810.041 0.045
Concurrent ventricular hemorrhage1.3870.5583.4460.482
Model 2
Male2.9510.71912.1180.133
Age1.0130.9701.0580.546
NLRT2 1.1121.0321.199 0.006
ICH volume1.0321.0101.054 0.004
GCS score0.8920.7471.0660.209
Infratentorial hemorrhage4.0210.84019.2500.082
Concurrent ventricular hemorrhage2.1430.4949.2900.309
Model 3
Male2.5870.50713.1990.253
Age1.0080.9581.0600.771
NLRT3 1.1631.0671.268 0.001
ICH volume1.0331.0081.058 0.011
GCS score0.9260.7521.1410.471
Infratentorial hemorrhage4.7670.77629.2890.092
Concurrent ventricular hemorrhage1.8310.31710.5720.499

GCS, Glasgow coma scale; ICH, intracerebral hemorrhage; NLR, neutrophil‐to‐lymphocyte ratio.

The bold values indicate P < 0.05.

Potential factors associated with 30‐day mortality: results of multivariate regression GCS, Glasgow coma scale; ICH, intracerebral hemorrhage; NLR, neutrophil‐to‐lymphocyte ratio. The bold values indicate P < 0.05. Spearman correlation analysis showed that NLRT2 and NLRT3 correlated positively with hemorrhage volume, ICH scores, and mortality, and negatively with GCS score (all P < 0.05; Table 3). NLRT1 did not correlate with any variables.
Table 3

Correlation of NLR with clinical features at various time points

NLRT1 NLRT2 NLRT3
r P r P r P
Male0.1120.0640.0860.2050.0700.377
Age0.0970.1080.148 0.028 0.1170.137
ICH volume0.0710.2430.477 <0.001 0.261 0.001
Infratentorial hemorrhage0.0170.7780.1200.0750.0650.413
Concurrent ventricular hemorrhage0.1030.0890.1100.1010.0330.679
GCS score−0.0420.488−0.436 <0.001 −0.373 <0.001
ICH score0.0320.5930.339 <0.001 0.271 <0.001
Death0.0950.1180.333 <0.001 0.284 <0.001

GCS, Glasgow coma scale; ICH, intracerebral hemorrhage; NLR, neutrophil‐to‐lymphocyte ratio; T1, at admission; T2, at 24‐48 h after admission; T3, at 5‐7 d after admission.

The bold values indicate P < 0.05.

Correlation of NLR with clinical features at various time points GCS, Glasgow coma scale; ICH, intracerebral hemorrhage; NLR, neutrophil‐to‐lymphocyte ratio; T1, at admission; T2, at 24‐48 h after admission; T3, at 5‐7 d after admission. The bold values indicate P < 0.05.

DISCUSSION

The present study found early increase in NLR after admission in subjects who died within 30 days. NLR within the first week after admission (both 24‐48 hours and 5‐7 days), but not upon admission, closely correlated with 30‐day mortality. Inflammatory response plays an important role in spontaneous ICH. Higher number of leukocytes, neutrophils, mononuclear cells, and other inflammatory cells correlates with poorer prognosis.21, 22, 23 As a surrogate marker for inflammation, NLR is not influenced by exercise and dehydration.24 In patients with spontaneous ICH, NLR is closely related to enlargement of hematoma17 and predicts 30‐day morbidity and mortality.13 Increased NLR is also related to increased 90‐day morbidity and mortality and decreased quality of life,14 and has been shown to be an independent risk for ICH development in diabetic patients.25 NLR increases with severity of hemorrhagic transformation and with time following cerebral thrombolysis.15 Given that fact that inflammation occurs through all stages in patients with spontaneous ICH,26 it is reasonable to speculate that NLR could reflect ICH progression. However, at what time point(s) NLR could serve as an ideal prognostic indicator remains unknown. Consistent with those of previous reports,27, 28, 29 subjects who died within 30 days in our study had significantly higher ICH volume and ICH score and lower GCS score. Many factors may have contributed to the correlation between NLR and 30‐day mortality. A previous study showed that leukocytes start to accumulate around and infiltrate the hematoma as early as 5 hours after ICH.30 At 1‐3 days after ICH, macrophages start to infiltrate the hematoma, with a plateau at 7‐10 days after ICH.31 In the current study, both NLR and ICH volume increased at 24 hours after ICH; such changes may reflect infiltration of inflammatory cells around the hematoma. We also found that NLR positively correlated with ICH volume, which is an important determinant of ICH mortality. In contrast to the early NLR increase in subjects who died within 30 days, patients who survived had relatively stable NLR level within the first week after hospitalization, emphasizing the need to monitor the dynamic changes in NLR within this period of time. Upon ICH, inflammatory cells that infiltrate the lesions and surrounding tissues activate glial cells, which in turn release pro‐inflammatory cytokines, thus forming a vicious cycle.32 Starting approximately 24 hours after ICH onset, the release of cytotoxic substances including hemoglobin, heme, and iron further aggravates the condition.33 With the progression of ICH, apoptosis of cells become apparent, thus worsening the inflammatory response.34 In the current study as well as an earlier report from this group of researchers, NLR at the time of admission (roughly 6 hours after disease onset) did not correlate with 30‐day mortality. Such findings possibly reflect delayed inflammatory response in elderly patients.35 The current study has several limitations. First, its retrospective design and relatively small sample prevent conclusions about the potentially causal relationships. Second, the study was conducted based on patients hospitalized in a secondary hospital away from major metropolitan centers. As a result, subjects in the current study had generally less severe conditions. Such a notion is supported by the considerably lower mortality at 14.5% vs 40%‐60% mortality in a previous report by Hemphill and colleagues.20 This discrepancy may limit the extrapolation of our findings to severe ICH patients. Lack of influence of patient age on mortality reflects, in our opinion, mostly due to the generally less ill patients in the current study. This speculation is supported by much lower mortality in our study vs that reported previously for ICH patients. For example, the mortality was 45% in a previous study by Hemphill and colleagues20 and only 14.5% in the current study despite of comparable age (66 ± 15 vs 66.4 ± 15.1 years of age; 21.7% vs 25.1% at >80 years). Intraventricular hemorrhage (IVH) is a proven risk factor of increased mortality and poor functional outcome.36 Lack of difference in the presence of IVH between the 2 groups could be due to the relatively low rate of IVH in the current study (25.8%) vs 55% in the Hemphill study,20 which in turn, could have attributed to the low mortality.

CONCLUSION

In summary, the current study indicated substantial rise in NLR within the first week after hospitalization, but only in those died within 30 days and not in those surviving beyond 30 days. Future prospective studies are needed to validate this finding. Also, the mechanisms underlying such an association need further investigation.

CONFLICT OF INTEREST

The authors declare no conflict of interest.
  36 in total

1.  Neutrophil-to-Lymphocyte Ratio Predicts the Outcome of Acute Intracerebral Hemorrhage.

Authors:  Simona Lattanzi; Claudia Cagnetti; Leandro Provinciali; Mauro Silvestrini
Journal:  Stroke       Date:  2016-05-10       Impact factor: 7.914

2.  Risk factors of early death in patients with hypertensive intracerebral hemorrhage during hospitalization.

Authors:  Xiao Hu; John H Zhang; Xinyue Qin
Journal:  Acta Neurochir Suppl       Date:  2011

Review 3.  Management of non-traumatic intraventricular hemorrhage.

Authors:  Thomas Gaberel; Christian Magheru; Evelyne Emery
Journal:  Neurosurg Rev       Date:  2012-06-26       Impact factor: 3.042

4.  Correlation of leukocytosis with early neurological deterioration following supratentorial intracerebral hemorrhage.

Authors:  Wei Sun; Amanda Peacock; Jane Becker; Barbara Phillips-Bute; Daniel T Laskowitz; Michael L James
Journal:  J Clin Neurosci       Date:  2012-06-16       Impact factor: 1.961

Review 5.  Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention.

Authors:  Ranjith Babu; Jacob H Bagley; Chunhui Di; Allan H Friedman; Cory Adamson
Journal:  Neurosurg Focus       Date:  2012-04       Impact factor: 4.047

6.  Admission neutrophil count and neutrophil to lymphocyte ratio predict 90-day outcome in intracerebral hemorrhage.

Authors:  Chuanyuan Tao; Xin Hu; Jiajing Wang; Junpeng Ma; Hao Li; Chao You
Journal:  Biomark Med       Date:  2016-12-05       Impact factor: 2.851

7.  Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality.

Authors:  J P Broderick; T G Brott; J E Duldner; T Tomsick; G Huster
Journal:  Stroke       Date:  1993-07       Impact factor: 7.914

8.  Early cellular events in the penumbra of human spontaneous intracerebral hemorrhage.

Authors:  J M Mackenzie; J A Clayton
Journal:  J Stroke Cerebrovasc Dis       Date:  1999 Jan-Feb       Impact factor: 2.136

9.  Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors.

Authors:  R Leira; A Dávalos; Y Silva; A Gil-Peralta; J Tejada; M Garcia; J Castillo
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

10.  Association between neutrophil to lymphocyte ratio and severity of coronary artery disease.

Authors:  Hasan Kaya; Faruk Ertaş; Yahya İslamoğlu; Zekeriya Kaya; Zuhal Arıtürk Atılgan; Habib Çil; Ahmet Çalışkan; Mesut Aydın; Mustafa Oylumlu; Mehmet Serdar Soydinç
Journal:  Clin Appl Thromb Hemost       Date:  2012-07-11       Impact factor: 2.389

View more
  14 in total

1.  Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update.

Authors:  Honglei Ren; Ranran Han; Xuemei Chen; Xi Liu; Jieru Wan; Limin Wang; Xiuli Yang; Jian Wang
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-19       Impact factor: 6.200

2.  Prognostic role of the preoperative neutrophil-to-lymphocyte ratio and albumin for 30-day mortality in patients with postoperative acute pulmonary embolism.

Authors:  Chuan Liu; Hui-Lu Zhan; Zhang-Heng Huang; Chuan Hu; Yue-Xin Tong; Zhi-Yi Fan; Meng-Ying Zheng; Cheng-Liang Zhao; Gui-Yun Ma
Journal:  BMC Pulm Med       Date:  2020-06-24       Impact factor: 3.317

Review 3.  Changes in Cerebral Blood Flow and Diffusion-Weighted Imaging Lesions After Intracerebral Hemorrhage.

Authors:  Jingfei Yang; Jie Jing; Shiling Chen; Xia Liu; Yingxin Tang; Chao Pan; Zhouping Tang
Journal:  Transl Stroke Res       Date:  2022-03-19       Impact factor: 6.800

4.  Association of Neutrophil-to-Lymphocyte Ratio with the Risk of Fatal Stroke Occurrence in Older Chinese.

Authors:  Zhi-Bing Hu; Qiong-Qiong Zhong; Ze-Xiong Lu; Feng Zhu
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

5.  Early increased neutrophil-to-lymphocyte ratio is associated with poor 3-month outcomes in spontaneous intracerebral hemorrhage.

Authors:  Jie Qin; Zhu Li; Guangming Gong; Hongwei Li; Ling Chen; Bo Song; Xinjing Liu; Changhe Shi; Jing Yang; Ting Yang; Yuming Xu
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

6.  Inhibition of activator protein 1 attenuates neuroinflammation and brain injury after experimental intracerebral hemorrhage.

Authors:  Chang-Juan Wei; Yu-Lin Li; Zi-Long Zhu; Dong-Mei Jia; Mo-Li Fan; Ting Li; Xue-Jiao Wang; Zhi-Guo Li; Hong-Shan Ma
Journal:  CNS Neurosci Ther       Date:  2019-08-08       Impact factor: 5.243

7.  Neutrophil-to-lymphocyte ratio predicts hematoma growth in intracerebral hemorrhage.

Authors:  Zhigang Wang; Qingyong Gong; Cheng Guo; Yong Luo; Lvan Chen
Journal:  J Int Med Res       Date:  2019-05-24       Impact factor: 1.671

8.  Excessive antibiotics use increased in-hospital mortality in intracerebral hemorrhage patients with stroke-associated infection.

Authors:  Fei Wang; Yinghua Wang; Junfeng Shi; Lijuan Shen; Xinyu Xu; Ting-Ting Jiang; Li Wang; Qing Chang; Shanyou Hu; Xiao Wu
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

9.  Early elevated neutrophil-to-lymphocyte ratio associated with remote diffusion-weighted imaging lesions in acute intracerebral hemorrhage.

Authors:  Jia-Wen Li; Yu-Yu Xu; Ye-Jun Chen; Wei-Wei Fan; Xu-Hua Xu; Jin-Song Cai; Lu-Sha Tong; Feng Gao
Journal:  CNS Neurosci Ther       Date:  2019-10-25       Impact factor: 5.243

10.  Machine learning models predict coagulopathy in spontaneous intracerebral hemorrhage patients in ER.

Authors:  Fengping Zhu; Zhiguang Pan; Ying Tang; Pengfei Fu; Sijie Cheng; Wenzhong Hou; Qi Zhang; Hong Huang; Yirui Sun
Journal:  CNS Neurosci Ther       Date:  2020-11-28       Impact factor: 7.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.